An observational study in Hyperlipidemias, sponsored by Muğla Sıtkı Koçman University. Status unknown. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2015-11-20.
Sponsored by Muğla Sıtkı Koçman University · Observational
In this study, within the secondary prevention group patients ( diabetes mellitus, coronary artery disease, peripheral artery disease, who have had events atherosclerotic cerebrovascular ) , statin use requirement , patients compliance and reaching target LDL-cholesterol levels (according to European guidelines ) will be evaluated.
In the majority of patients treated with lipid lowering agents are not under control in accordance with the lipids manual. In this study, within the secondary prevention group patients ( diabetes mellitus, coronary artery disease, peripheral artery disease, who have had events atherosclerotic cerebrovascular ) , statin use requirement , patients compliance and reaching target LDL-cholesterol levels (according to European guidelines ) will be evaluated.
The investigators' aim is to determine the role of education and knowledge in reaching target LDL cholesterol levels in these patients. İn addition , the investigators want to emphasize in high-risk patients who are receiving or not receiving cholesterol-lowering treatment what is their target values , (LDL \< 100 mg / dL and high -risk patients with LDL \< 70 mg / dL in very high-risk patients ) and to determine what is the rate of patients and to the importance of reaching their target cholesterol levels. İn addition ,to evaluate the patients habits of the using statin dose .After screening , physician treatment decisions and reasons will be documented.
1,238 studies on the registry are indexed under Hypercholesterolemia; 109 are open to participants now.
This study's planned enrollment of 6,000 is above the median of 800 across 185 observational studies indexed under Hypercholesterolemia.
Browse Hypercholesterolemia studies →Muğla Sıtkı Koçman University is the lead sponsor of 112 studies on the registry; 19 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients receiving lipid-lowering therapy within the secondary prevention group in Turkey
Exclusion Criteria:
The number of patients with secondary prevention group receiving appropriate lipid lowering therapy
Time frame: 2 months
No study locations are listed for this record.
This study is status unknown, as verified in Nov 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Muğla Sıtkı Koçman University